Capstan Therapeutics logo

Capstan Therapeutics

Emerging

Capstan Therapeutics develops in vivo RNA-based therapies using targeted lipid nanoparticles to engineer immune cells inside the body without ex vivo manufacturing; raised $165M Series A in 2022; targeting oncology, fibrosis, and autoimmune diseases.

Best for: In Vivo RNA Cell Engineering & Gene TherapyEmerging, rapid growth
34
AI Score
Grade D
AI Visibility Score (Beta)
Life Sciences & BioTechIn Vivo RNA Cell Engineering & Gene TherapyWebsiteUpdated October 2026

Company Overview

About Capstan Therapeutics

Capstan Therapeutics is a biopharmaceutical company founded in 2021 and headquartered in Philadelphia, Pennsylvania, with scientific co-founders including Drew Weissman (2023 Nobel Prize in Medicine laureate for mRNA technology) and Carl June (pioneer of CAR-T cell therapy). The company is developing a novel class of in vivo RNA-based medicines that use targeted lipid nanoparticles (LNPs) to deliver genetic instructions directly into specific immune cells inside the patient's body — enabling the creation of therapeutic immune cells (similar to CAR-T cells) without the costly and time-consuming ex vivo manufacturing process that currently requires extracting, engineering, and re-infusing a patient's cells outside the body.

Business Model & Competitive Advantage

Capstan raised a $165M Series A in 2022 led by a16z Bio and Newpath Partners, with participation from OrbiMed, 5AM Ventures, and other life sciences investors — one of the largest Series A rounds in biotechnology that year. The company's platform targets oncology (particularly blood cancers and solid tumors), fibrosis, and inflammation-related diseases. If successful, Capstan's approach could democratize cell therapy by eliminating the manufacturing bottleneck that limits current CAR-T therapies to a fraction of patients who could benefit, while dramatically reducing the cost and vein-to-vein time (currently weeks for ex vivo CAR-T).

Competitive Landscape 2025–2026

Capstan competes in the in vivo cell engineering space with companies including Umoja Biopharma, Orca Bio, and Cargo Therapeutics, as well as established CAR-T manufacturers (Novartis, Bristol Myers Squibb, Kite/Gilead) that are exploring in vivo approaches. The company's co-founder pedigree — combining the inventors of the mRNA technology underlying COVID vaccines with the pioneer of CAR-T — gives it exceptional scientific credibility in a field where platform differentiation is critical.

Founded
2021
Headquarters
Philadelphia, Pennsylvania
Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Capstan Therapeutics is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

34
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

Neuralink logo

Neuralink

Life Sciences & BioTech
HealthtechHardwareAi PoweredB2b2cStartupDecacornNorth AmericaTechnologyPlatformEnterprise

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa

Saluda Medical logo

Saluda Medical

Life Sciences & BioTech
HealthtechHardwareB2bGlobalStartupAi Powered

Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

ConcertAI logo

ConcertAI

Life Sciences & BioTech
HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn

ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult

DNAnexus logo

DNAnexus

Life Sciences & BioTech
B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure

DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a

For Capstan Therapeutics

Claim This Profile

Are you from Capstan Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Capstan Therapeutics Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Capstan Therapeutics vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →